Click here to get full coverage on Kilitch Drugs (India) Limited Revenue Breakdown – NSE:KILITCH - TradingView

Kilitch Drugs (India) Limited Revenue Breakdown – NSE:KILITCH  TradingView

Kilitch Drugs (India) Limited Revenue Breakdown – NSE:KILITCH - TradingView

Click here to get full coverage on Kilitch Drugs schedules 34th AGM for Aug 27 via VC/OAVM - scanx.trade

Kilitch Drugs schedules 34th AGM for Aug 27 via VC/OAVM  scanx.trade

Kilitch Drugs schedules 34th AGM for Aug 27 via VC/OAVM - scanx.trade

Click here to get full coverage on Kilitch Drugs Commences Production At New Raigad Facility, Targeting ₹75 Cr Incremental Revenue - Sahi

Kilitch Drugs Commences Production At New Raigad Facility, Targeting ₹75 Cr Incremental Revenue  Sahi

Kilitch Drugs Commences Production At New Raigad Facility, Targeting ₹75 Cr Incremental Revenue - Sahi

Click here to get full coverage on Kilitch Drugs (India) consolidated net profit rises 39.62% in the March 2026 quarter - Business Standard

Kilitch Drugs (India) consolidated net profit rises 39.62% in the March 2026 quarter  Business Standard

Kilitch Drugs (India) consolidated net profit rises 39.62% in the March 2026 quarter - Business Standard

Click here to get full coverage on Kilitch Starts New Nutraceutical Block; Shares Slip 0.5% - HDFC Sky

Kilitch Starts New Nutraceutical Block; Shares Slip 0.5%  HDFC Sky

Kilitch Starts New Nutraceutical Block; Shares Slip 0.5% - HDFC Sky

Click here to get full coverage on FDA lambasts Kilitch for unsanitary manufacturing conditions and issues warning letter to Natco, too - Fierce Pharma

FDA lambasts Kilitch for unsanitary manufacturing conditions and issues warning letter to Natco, too  Fierce Pharma

FDA lambasts Kilitch for unsanitary manufacturing conditions and issues warning letter to Natco, too - Fierce Pharma

Click here to get full coverage on Bonus Shares This Week: Check Record Date For Kilitch Drugs, Times Green Energy - NDTV Profit

Bonus Shares This Week: Check Record Date For Kilitch Drugs, Times Green Energy  NDTV Profit

Bonus Shares This Week: Check Record Date For Kilitch Drugs, Times Green Energy - NDTV Profit

Click here to get full coverage on Kilitch Drugs India Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook - Univest

Kilitch Drugs India Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook  Univest

Kilitch Drugs India Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook - Univest

Click here to get full coverage on Kilitch Drugs Standalone March 2026 Net Sales at Rs 71.97 crore, up 27.82% Y-o-Y - Moneycontrol.com

Kilitch Drugs Standalone March 2026 Net Sales at Rs 71.97 crore, up 27.82% Y-o-Y  Moneycontrol.com

Kilitch Drugs Standalone March 2026 Net Sales at Rs 71.97 crore, up 27.82% Y-o-Y - Moneycontrol.com

Click here to get full coverage on Kilitch Drugs - 10 stocks Mukul Agrawal bought in September quarter amid Rs 7,700 crore portfolio reshuffle - The Economic Times

Kilitch Drugs - 10 stocks Mukul Agrawal bought in September quarter amid Rs 7,700 crore portfolio reshuffle  The Economic Times

Kilitch Drugs - 10 stocks Mukul Agrawal bought in September quarter amid Rs 7,700 crore portfolio reshuffle - The Economic Times

Click here to get full coverage on Kilitch Drugs H! FY26 PAT up 18% YoY to Rs. 10.30 Cr - Indian Pharma Post

Kilitch Drugs H! FY26 PAT up 18% YoY to Rs. 10.30 Cr  Indian Pharma Post

Kilitch Drugs H! FY26 PAT up 18% YoY to Rs. 10.30 Cr - Indian Pharma Post

Click here to get full coverage on More Eye Drops Recalled After FDA Warning - AARP

More Eye Drops Recalled After FDA Warning  AARP

More Eye Drops Recalled After FDA Warning - AARP

Click here to get full coverage on Indian manufacturer recalls eyedrops previously cited in FDA warning - pbs.org

Indian manufacturer recalls eyedrops previously cited in FDA warning  pbs.org

Indian manufacturer recalls eyedrops previously cited in FDA warning - pbs.org

Click here to get full coverage on Kilitch Drugs (India) Ltd. Schedules Board Meeting on May 15, 2026 to Approve Q4FY26 Financial Results - scanx.trade

Kilitch Drugs (India) Ltd. Schedules Board Meeting on May 15, 2026 to Approve Q4FY26 Financial Results  scanx.trade

Kilitch Drugs (India) Ltd. Schedules Board Meeting on May 15, 2026 to Approve Q4FY26 Financial Results - scanx.trade

Click here to get full coverage on Kilitch Drugs (India) Q1 FY27 Results Preview - Univest

Kilitch Drugs (India) Q1 FY27 Results Preview  Univest

Kilitch Drugs (India) Q1 FY27 Results Preview - Univest

Click here to get full coverage on Dividend, bonus issue: PFC, 4 others to remain in focus; do you own any? - Business Standard

Dividend, bonus issue: PFC, 4 others to remain in focus; do you own any?  Business Standard

Dividend, bonus issue: PFC, 4 others to remain in focus; do you own any? - Business Standard

Click here to get full coverage on Kilitch Drugs posts 4% PAT rise in FY26, seeks ₹2 cr exec pay - scanx.trade

Kilitch Drugs posts 4% PAT rise in FY26, seeks ₹2 cr exec pay  scanx.trade

Kilitch Drugs posts 4% PAT rise in FY26, seeks ₹2 cr exec pay - scanx.trade

Click here to get full coverage on Kilitch Drugs commences nutraceutical production at Raigad facility - scanx.trade

Kilitch Drugs commences nutraceutical production at Raigad facility  scanx.trade

Kilitch Drugs commences nutraceutical production at Raigad facility - scanx.trade

Click here to get full coverage on Kilitch Drugs confirms no share encumbrance in FY26 - scanx.trade

Kilitch Drugs confirms no share encumbrance in FY26  scanx.trade

Kilitch Drugs confirms no share encumbrance in FY26 - scanx.trade

Click here to get full coverage on Kilitch Drugs FY26 Net Profit Rises to ₹2,950.03 Lakhs - scanx.trade

Kilitch Drugs FY26 Net Profit Rises to ₹2,950.03 Lakhs  scanx.trade

Kilitch Drugs FY26 Net Profit Rises to ₹2,950.03 Lakhs - scanx.trade

Click here to get full coverage on Another eye drop recall pulls 28 products off of CVS, Rite Aid, Target and Walmart shelves after FDA warning - CBS News

Another eye drop recall pulls 28 products off of CVS, Rite Aid, Target and Walmart shelves after FDA warning  CBS News

Another eye drop recall pulls 28 products off of CVS, Rite Aid, Target and Walmart shelves after FDA warning - CBS News

Click here to get full coverage on Kilitch drugs to raise ₹50 cr via rights issue to fund expansion - pharma.economictimes.indiatimes.com

Kilitch drugs to raise ₹50 cr via rights issue to fund expansion  pharma.economictimes.indiatimes.com

Kilitch drugs to raise ₹50 cr via rights issue to fund expansion - pharma.economictimes.indiatimes.com

Click here to get full coverage on Kilitch Drugs (India) Limited Schedules EGM for March 13, 2026 to Increase Authorized Capital and Issue Bonus Shares - scanx.trade

Kilitch Drugs (India) Limited Schedules EGM for March 13, 2026 to Increase Authorized Capital and Issue Bonus Shares  scanx.trade

Kilitch Drugs (India) Limited Schedules EGM for March 13, 2026 to Increase Authorized Capital and Issue Bonus Shares - scanx.trade

Click here to get full coverage on Ace Investor Mukul Agrawal Picks Stake in this Smallcap Pharma Stock - Equitymaster

Ace Investor Mukul Agrawal Picks Stake in this Smallcap Pharma Stock  Equitymaster

Ace Investor Mukul Agrawal Picks Stake in this Smallcap Pharma Stock - Equitymaster

Click here to get full coverage on Buy Kilitch Drugs Ltd For Target Rs.464 By Sushil Finance - Investment Guru India

Buy Kilitch Drugs Ltd For Target Rs.464 By Sushil Finance  Investment Guru India

Buy Kilitch Drugs Ltd For Target Rs.464 By Sushil Finance - Investment Guru India

Click here to get full coverage on Tainted eyedrops pulled by CVS, Target made by barefoot workers in India: report - New York Post

Tainted eyedrops pulled by CVS, Target made by barefoot workers in India: report  New York Post

Tainted eyedrops pulled by CVS, Target made by barefoot workers in India: report - New York Post

Click here to get full coverage on Kilitch Drugs Sets March 24 Record Date for 1:1 Bonus Share Issue - scanx.trade

Kilitch Drugs Sets March 24 Record Date for 1:1 Bonus Share Issue  scanx.trade

Kilitch Drugs Sets March 24 Record Date for 1:1 Bonus Share Issue - scanx.trade

Click here to get full coverage on FDA recalls another 27 eye drops made in ‘insanitary’ plant where operators work barefoot - New York Post

FDA recalls another 27 eye drops made in ‘insanitary’ plant where operators work barefoot  New York Post

FDA recalls another 27 eye drops made in ‘insanitary’ plant where operators work barefoot - New York Post

Click here to get full coverage on Barefoot workers, bacteria found at factory that made big-brand eye drops - Ars Technica

Barefoot workers, bacteria found at factory that made big-brand eye drops  Ars Technica

Barefoot workers, bacteria found at factory that made big-brand eye drops - Ars Technica

Click here to get full coverage on Kilitch Drugs Manufacturing Plant - Pharmaceutical Technology

Kilitch Drugs Manufacturing Plant  Pharmaceutical Technology

Kilitch Drugs Manufacturing Plant - Pharmaceutical Technology

Click here to get full coverage on Kilitch Drugs post ₹10 crore net profit in Q4 FY25 - pharma.economictimes.indiatimes.com

Kilitch Drugs post ₹10 crore net profit in Q4 FY25  pharma.economictimes.indiatimes.com

Kilitch Drugs post ₹10 crore net profit in Q4 FY25 - pharma.economictimes.indiatimes.com

Click here to get full coverage on USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plant - The Economic Times

USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plant  The Economic Times

USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plant - The Economic Times

Click here to get full coverage on USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plant - ET Manufacturing

USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plant  ET Manufacturing

USFDA issues warning letter to Kilitch Healthcare for Navi-Mumbai plant - ET Manufacturing

Click here to get full coverage on USFDA issues 'warning letter' to Kilitch Healthcare over GMP violation - Business Standard

USFDA issues 'warning letter' to Kilitch Healthcare over GMP violation  Business Standard

USFDA issues 'warning letter' to Kilitch Healthcare over GMP violation - Business Standard

Click here to get full coverage on Despite global volatility India’s pharma exports continue to demonstrate steady resilience - Express Pharma

Despite global volatility India’s pharma exports continue to demonstrate steady resilience  Express Pharma

Despite global volatility India’s pharma exports continue to demonstrate steady resilience - Express Pharma

Click here to get full coverage on KILITCH Stock Price and Chart — NSE:KILITCH - TradingView

KILITCH Stock Price and Chart — NSE:KILITCH  TradingView

KILITCH Stock Price and Chart — NSE:KILITCH - TradingView

Click here to get full coverage on Kilitch Drugs (India) Ltd. Share Price Today | Kilitch Drugs Live NSE/BSE - Value Research

Kilitch Drugs (India) Ltd. Share Price Today | Kilitch Drugs Live NSE/BSE  Value Research

Kilitch Drugs (India) Ltd. Share Price Today | Kilitch Drugs Live NSE/BSE - Value Research

Click here to get full coverage on Kilitch Drugs eyes Rs 1,000 crore revenue with Khopoli expansion regulated market entry - Moneycontrol.com

Kilitch Drugs eyes Rs 1,000 crore revenue with Khopoli expansion regulated market entry  Moneycontrol.com

Kilitch Drugs eyes Rs 1,000 crore revenue with Khopoli expansion regulated market entry - Moneycontrol.com

Click here to get full coverage on Kilitch Drug India's subsidiary wins tender in Ethiopia - Indian Pharma Post

Kilitch Drug India's subsidiary wins tender in Ethiopia  Indian Pharma Post

Kilitch Drug India's subsidiary wins tender in Ethiopia - Indian Pharma Post

Click here to get full coverage on Kilitch Drugs to raise around ₹50 crore via rights issue at Rs. 375 per share - Express Pharma

Kilitch Drugs to raise around ₹50 crore via rights issue at Rs. 375 per share  Express Pharma

Kilitch Drugs to raise around ₹50 crore via rights issue at Rs. 375 per share - Express Pharma

Click here to get full coverage on Kilitch Drugs posts consolidated Q4 FY25 PAT at Rs. 10.21 Cr - Indian Pharma Post

Kilitch Drugs posts consolidated Q4 FY25 PAT at Rs. 10.21 Cr  Indian Pharma Post

Kilitch Drugs posts consolidated Q4 FY25 PAT at Rs. 10.21 Cr - Indian Pharma Post

Click here to get full coverage on Kilitch Drugs earmarks Rs. 100 crore as part of its expansion - Indian Pharma Post

Kilitch Drugs earmarks Rs. 100 crore as part of its expansion  Indian Pharma Post

Kilitch Drugs earmarks Rs. 100 crore as part of its expansion - Indian Pharma Post

Click here to get full coverage on Trade promotion body Pharmexcil names Bhavin Mehta as next Vice-Chairman - pharma.economictimes.indiatimes.com

Trade promotion body Pharmexcil names Bhavin Mehta as next Vice-Chairman  pharma.economictimes.indiatimes.com

Trade promotion body Pharmexcil names Bhavin Mehta as next Vice-Chairman - pharma.economictimes.indiatimes.com

Click here to get full coverage on Kilitch Drugs India | Stock Share Price Live - MarketSmith India

Kilitch Drugs India | Stock Share Price Live  MarketSmith India

Kilitch Drugs India | Stock Share Price Live - MarketSmith India

Click here to get full coverage on Pharmexcil appoints Bhavin Mehta as Vice-Chairman - Express Pharma

Pharmexcil appoints Bhavin Mehta as Vice-Chairman  Express Pharma

Pharmexcil appoints Bhavin Mehta as Vice-Chairman - Express Pharma

Click here to get full coverage on Kilitch Drugs (India) Limited's Subsidiary Won Tender Issued by the Ethiopian Pharmaceutical Supply Service of the Federal Democratic Republic of Ethiopia - ANI News

Kilitch Drugs (India) Limited's Subsidiary Won Tender Issued by the Ethiopian Pharmaceutical Supply Service of the Federal Democratic Republic of Ethiopia  ANI News

Kilitch Drugs (India) Limited's Subsidiary Won Tender Issued by the Ethiopian Pharmaceutical Supply Service of the Federal Democratic Republic of Ethiopia - ANI News

Click here to get full coverage on Kilitch Drugs starts Rs. 100 crore New Facility Expansion Plan - Medical Dialogues

Kilitch Drugs starts Rs. 100 crore New Facility Expansion Plan  Medical Dialogues

Kilitch Drugs starts Rs. 100 crore New Facility Expansion Plan - Medical Dialogues

Click here to get full coverage on Kilitch Drugs plans to start manufacturing operations in Ethiopia, Africa - Express Pharma

Kilitch Drugs plans to start manufacturing operations in Ethiopia, Africa  Express Pharma

Kilitch Drugs plans to start manufacturing operations in Ethiopia, Africa - Express Pharma

Click here to get full coverage on Kilitch Drugs to set-up second green field project in Ethiopia at an investment of $5 mn - Express Pharma

Kilitch Drugs to set-up second green field project in Ethiopia at an investment of $5 mn  Express Pharma

Kilitch Drugs to set-up second green field project in Ethiopia at an investment of $5 mn - Express Pharma

Click here to get full coverage on Kilitch Drugs Postpones Rights Issue Allotment Process by Three Days - scanx.trade

Kilitch Drugs Postpones Rights Issue Allotment Process by Three Days  scanx.trade

Kilitch Drugs Postpones Rights Issue Allotment Process by Three Days - scanx.trade

Click here to get full coverage on Kilitch Drugs starts Rs. 100 crore New Facility Expansion Plan - ThePrint

Kilitch Drugs starts Rs. 100 crore New Facility Expansion Plan  ThePrint

Kilitch Drugs starts Rs. 100 crore New Facility Expansion Plan - ThePrint

Click here to get full coverage on Recovering Sudanese markets helps Kilitch Drugs improve financial performance in FY2020 - ANI News

Recovering Sudanese markets helps Kilitch Drugs improve financial performance in FY2020  ANI News

Recovering Sudanese markets helps Kilitch Drugs improve financial performance in FY2020 - ANI News

Click here to get full coverage on Bhavin Mukund Mehta steps in as Vice-Chairman of Pharmexcil - BioSpectrum India

Bhavin Mukund Mehta steps in as Vice-Chairman of Pharmexcil  BioSpectrum India

Bhavin Mukund Mehta steps in as Vice-Chairman of Pharmexcil - BioSpectrum India

Click here to get full coverage on SGRL Stock Price and Chart — BSE:SGRL - TradingView

SGRL Stock Price and Chart — BSE:SGRL  TradingView

SGRL Stock Price and Chart — BSE:SGRL - TradingView

Click here to get full coverage on Kilitch Drugs India forms JV in Ethiopia with local partner - ET HealthWorld

Kilitch Drugs India forms JV in Ethiopia with local partner  ET HealthWorld

Kilitch Drugs India forms JV in Ethiopia with local partner - ET HealthWorld

Click here to get full coverage on Kilitch Drugs (india) Rights Issue 2025 Date, Price, Allotment, Ratio - IPO Watch

Kilitch Drugs (india) Rights Issue 2025 Date, Price, Allotment, Ratio  IPO Watch

Kilitch Drugs (india) Rights Issue 2025 Date, Price, Allotment, Ratio - IPO Watch

Click here to get full coverage on Kilitch Drugs announces appointment of new members to the board - Express Pharma

Kilitch Drugs announces appointment of new members to the board  Express Pharma

Kilitch Drugs announces appointment of new members to the board - Express Pharma

Click here to get full coverage on Bhavin Mehta, Director, Kilitch Drugs - Express Pharma

Bhavin Mehta, Director, Kilitch Drugs  Express Pharma

Bhavin Mehta, Director, Kilitch Drugs - Express Pharma

Click here to get full coverage on Kilitch Drugs Rights Issue Date, Price, Market Lot, Subscription 2025 - IPO Central

Kilitch Drugs Rights Issue Date, Price, Market Lot, Subscription 2025  IPO Central

Kilitch Drugs Rights Issue Date, Price, Market Lot, Subscription 2025 - IPO Central

Click here to get full coverage on Kilitch Drug Share Price Today, Kilitch Drug Stock Price Live NSE/BSE Updates - The Economic Times

Kilitch Drug Share Price Today, Kilitch Drug Stock Price Live NSE/BSE Updates  The Economic Times

Kilitch Drug Share Price Today, Kilitch Drug Stock Price Live NSE/BSE Updates - The Economic Times

Click here to get full coverage on Kilitch Drugs to sell Himachal plant to US based Akron Inc for Rs 188 Cr - Hill Post

Kilitch Drugs to sell Himachal plant to US based Akron Inc for Rs 188 Cr  Hill Post

Kilitch Drugs to sell Himachal plant to US based Akron Inc for Rs 188 Cr - Hill Post

Click here to get full coverage on Indian Firm Begins Manufacturing Cephalosporin Injectables in Addis - Ethiopian Monitor

Indian Firm Begins Manufacturing Cephalosporin Injectables in Addis  Ethiopian Monitor

Indian Firm Begins Manufacturing Cephalosporin Injectables in Addis - Ethiopian Monitor

Click here to get full coverage on KILITCH DRUGS Share Price - Upstox

KILITCH DRUGS Share Price - Upstox

Click here to get full coverage on Lanka raps six Indian drug suppliers on quality issues - Business Standard

Lanka raps six Indian drug suppliers on quality issues  Business Standard

Lanka raps six Indian drug suppliers on quality issues - Business Standard

Click here to get full coverage on Kilitch Drugs (India) Ltd is Rated Hold - Markets Mojo

Kilitch Drugs (India) Ltd is Rated Hold  Markets Mojo

Kilitch Drugs (India) Ltd is Rated Hold - Markets Mojo

Click here to get full coverage on Kilitch Drugs Postpones Rights Issue Share Credit and Listing Dates - TipRanks

Kilitch Drugs Postpones Rights Issue Share Credit and Listing Dates  TipRanks

Kilitch Drugs Postpones Rights Issue Share Credit and Listing Dates - TipRanks

Click here to get full coverage on Kilitch Drugs Shares Hit 5% Lower Circuit After Q1 EBITDA Slumps 87% QoQ; Revenue Halves, Margin Falls to 6.5% - Business Upturn

Kilitch Drugs Shares Hit 5% Lower Circuit After Q1 EBITDA Slumps 87% QoQ; Revenue Halves, Margin Falls to 6.5%  Business Upturn

Kilitch Drugs Shares Hit 5% Lower Circuit After Q1 EBITDA Slumps 87% QoQ; Revenue Halves, Margin Falls to 6.5% - Business Upturn

Click here to get full coverage on 1:1 Bonus Issue: 2 Stocks in focus as they are set to turn ex-bonus tomorrow - Trade Brains

1:1 Bonus Issue: 2 Stocks in focus as they are set to turn ex-bonus tomorrow  Trade Brains

KILITCH

Price Chart

Key Statistics

Technicals

About KILITCH

Latest News

Kilitch Drugs (India) Limited Revenue Breakdown – NSE:KILITCH - TradingView

Kilitch Drugs schedules 34th AGM for Aug 27 via VC/OAVM - scanx.trade

Kilitch Drugs Commences Production At New Raigad Facility, Targeting ₹75 Cr Incremental Revenue - Sahi

Advanced Charts

Top Gainers

Top Losers